Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jun 13 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-1.44 Insider Own37.87% Shs Outstand10.65M Perf Week-5.80%
Market Cap24.28M Forward P/E- EPS next Y-0.91 Insider Trans0.20% Shs Float7.74M Perf Month-32.76%
Income-14.74M PEG- EPS next Q-0.33 Inst Own15.20% Short Float2.79% Perf Quarter-47.01%
Sales8.99M P/S2.70 EPS this Y24.72% Inst Trans59.10% Short Ratio6.30 Perf Half Y-36.89%
Book/sh-0.11 P/B- EPS next Y33.39% ROA-158.00% Short Interest0.22M Perf Year-35.43%
Cash/sh0.27 P/C7.12 EPS next 5Y- ROE-701.30% 52W Range1.74 - 6.75 Perf YTD-52.21%
Dividend Est.- P/FCF- EPS past 5Y5.77% ROI-3129.72% 52W High-71.11% Beta1.57
Dividend TTM- Quick Ratio1.11 Sales past 5Y25.92% Gross Margin58.84% 52W Low12.07% ATR (14)0.25
Dividend Ex-DateJul 07, 2017 Current Ratio1.16 EPS Y/Y TTM91.26% Oper. Margin-192.21% RSI (14)31.87 Volatility10.23% 11.86%
Employees64 Debt/Eq- Sales Y/Y TTM4.46% Profit Margin-163.95% Recom2.33 Target Price5.25
Option/ShortNo / Yes LT Debt/Eq- EPS Q/Q46.45% Payout- Rel Volume3.63 Prev Close1.86
Sales Surprise-16.00% EPS Surprise-17.19% Sales Q/Q-7.04% EarningsMay 15 BMO Avg Volume34.24K Price1.95
SMA20-15.69% SMA50-31.15% SMA200-50.48% Trades Volume118,520 Change4.84%
Date Action Analyst Rating Change Price Target Change
Jan-12-22Resumed Cantor Fitzgerald Overweight $4
Mar-29-21Initiated Truist Buy $12
Jan-29-21Initiated Cantor Fitzgerald Overweight $10
Oct-30-20Initiated William Blair Outperform
Jun-13-24 08:00AM
May-16-24 08:00AM
May-15-24 11:53AM
08:47AM Loading…
May-08-24 08:47AM
May-07-24 08:00AM
May-02-24 08:00AM
Apr-09-24 08:00AM
Apr-01-24 11:24AM
Mar-28-24 11:53AM
Mar-25-24 08:00AM
Mar-21-24 08:00AM
08:00AM Loading…
Mar-18-24 08:00AM
Mar-11-24 08:00AM
Feb-22-24 08:30AM
Feb-12-24 08:00AM
Feb-06-24 08:00AM
Jan-25-24 08:00AM
Dec-19-23 08:00AM
Dec-14-23 08:00AM
Dec-08-23 09:46AM
Dec-07-23 09:20AM
Dec-06-23 08:00AM
Nov-28-23 08:00AM
Nov-27-23 09:47AM
Nov-13-23 04:05PM
08:00AM Loading…
Nov-09-23 08:00AM
Oct-31-23 08:00AM
Oct-25-23 08:00AM
Oct-23-23 08:00AM
Oct-20-23 10:43AM
Sep-29-23 08:00AM
Sep-13-23 08:00AM
Sep-11-23 08:00AM
Aug-31-23 08:00AM
Aug-29-23 08:00AM
Aug-28-23 08:00AM
Aug-14-23 04:01PM
Aug-09-23 04:05PM
Jul-31-23 08:00AM
Jul-20-23 08:30AM
Jun-28-23 08:00AM
Jun-12-23 06:23PM
Jun-08-23 01:23PM
Jun-05-23 08:00AM
Jun-02-23 09:35AM
May-31-23 08:00AM
May-30-23 08:00AM
May-26-23 09:15AM
May-19-23 09:38AM
May-16-23 04:05PM
May-15-23 04:05PM
May-11-23 04:01PM
May-09-23 04:07PM
Apr-27-23 04:05PM
Mar-27-23 07:12AM
Mar-22-23 04:05PM
Mar-03-23 08:38AM
Jan-09-23 04:05PM
Jan-06-23 08:00AM
Dec-27-22 08:00AM
Nov-29-22 04:01PM
Nov-10-22 07:00AM
Nov-01-22 08:00AM
Oct-06-22 04:05PM
Oct-05-22 08:00AM
Sep-27-22 09:05AM
Sep-12-22 04:28PM
Aug-23-22 08:00AM
Aug-22-22 04:02PM
Aug-18-22 04:05PM
Aug-10-22 07:30AM
Aug-01-22 08:00AM
Jul-11-22 06:26AM
Jun-23-22 04:05PM
Jun-16-22 04:01PM
May-18-22 07:31AM
May-16-22 01:20PM
May-12-22 04:01PM
May-11-22 07:30AM
Apr-29-22 08:00AM
Apr-02-22 01:40PM
Mar-23-22 07:00AM
Mar-15-22 08:00AM
Feb-28-22 08:14AM
Feb-24-22 04:01PM
Feb-22-22 04:05PM
Feb-08-22 01:46PM
Aspira Women's Health, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sandford NicoleChief Executive OfficerMay 31 '24Buy2.429,49322,97370,596Jun 03 05:30 PM
Sandford NicolePresident & CEODec 06 '23Buy3.365,00016,80058,703Dec 06 05:21 PM
Merchant Minh HoangSecretary & General CounselDec 06 '23Sale3.379803,3030Dec 08 05:28 PM
Hombeck TorstenChief Financial OfficerSep 08 '23Buy4.302,2469,6583,000Sep 12 06:37 PM
SCHULER JACK W10% OwnerJul 24 '23Buy2.75181,800499,9501,883,656Jul 25 05:39 PM
Sandford NicolePresident & CEOJul 24 '23Buy3.9812,56350,001134,665Jul 25 05:16 PM
Herchuk Jannie PrestridgeDirectorJul 24 '23Buy3.988,79435,00023,833Jul 24 06:49 PM
Parnell WinfredDirectorJul 24 '23Buy3.986,28124,99831,513Jul 25 05:03 PM
Cavanaugh Stefanie L.DirectorJul 24 '23Buy3.986,28124,99834,904Jul 25 05:20 PM
Jordan Veronica GHDirectorJul 24 '23Buy3.983,76915,00134,575Jul 24 06:58 PM
Vos Ellen O'ConnorDirectorJul 24 '23Buy3.983,76915,00132,878Jul 26 04:28 PM
Merchant Minh HoangGeneral counsel and secretaryJul 24 '23Buy3.987543,0013,865Jul 25 04:58 PM
Fralick Celeste RachelleDirectorJul 24 '23Buy3.987543,00112,032Jul 26 07:28 PM
Hombeck TorstenChief Financial OfficerJul 24 '23Buy3.987543,001754Jul 24 06:53 PM
Phan Ryan ThinhCSO & COOJul 24 '23Buy3.986282,4993,939Jul 25 05:11 PM